Please login to the form below

Not currently logged in
Email:
Password:

Tabalumab

This page shows the latest Tabalumab news and features for those working in and with pharma, biotech and healthcare.

Lilly reports first pivotal data for Xeljanz rival in arthritis

Lilly reports first pivotal data for Xeljanz rival in arthritis

Meanwhile, the positive data for baricitinib in RA is a boost for Lilly's anti-inflammatory portfolio, which suffered a casualty in October when tabalumab was dropped from development.

Latest news

More from news
Approximately 2 fully matching, plus 10 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Pegasus

Pegasus inspires healthy decisions through creative, inspirational and integrated communications. Working with ambitious clients, we deliver big ideas and far-reaching...

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics